Cucchi DGJ[Author] - Search Results

Year	Number of Results
2018	1
2019	1
2020	4
2021	7
2022	7
2023	5
2024	1

1

Cucchi DGJ, Zweegman S. Cucchi DGJ, et al. Blood. 2023 Jul 20;142(3):212-214. doi: 10.1182/blood.2023020327. Blood. 2023. PMID: 37471108 No abstract available.

2

Two decades of targeted therapies in acute myeloid leukemia.

Cucchi DGJ, Polak TB, Ossenkoppele GJ, Uyl-De Groot CA, Cloos J, Zweegman S, Janssen JJWM. Cucchi DGJ, et al. Leukemia. 2021 Mar;35(3):651-660. doi: 10.1038/s41375-021-01164-x. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589753 Review.

3

The wider perspective: twenty years of clinical trials in myelodysplastic syndromes.

Duetz C, Cucchi DGJ, Polak TB, Janssen JJWM, Ossenkoppele GJ, Estey EH, van de Loosdrecht AA. Duetz C, et al. Among authors: cucchi dgj. Br J Haematol. 2022 Jan;196(2):329-335. doi: 10.1111/bjh.17892. Epub 2021 Oct 10. Br J Haematol. 2022. PMID: 34632583 Review.

4

Real-world data from expanded access programmes in health technology assessments: a review of NICE technology appraisals.

Polak TB, Cucchi DGJ, van Rosmalen J, Uyl-de Groot CA. Polak TB, et al. Among authors: cucchi dgj. BMJ Open. 2022 Jan 6;12(1):e052186. doi: 10.1136/bmjopen-2021-052186. BMJ Open. 2022. PMID: 34992108 Free PMC article. Review.

5

Treatment sequences and drug costs from diagnosis to death in multiple myeloma.

Seefat MR, Cucchi DGJ, Groen K, Donker ML, van der Hem KG, Westerman M, Gerrits AM, Beeker A, van de Donk NWCJ, Blommestein HM, Zweegman S. Seefat MR, et al. Among authors: cucchi dgj. Eur J Haematol. 2024 Mar;112(3):360-366. doi: 10.1111/ejh.14119. Epub 2023 Oct 11. Eur J Haematol. 2024. PMID: 37821211

6

A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma.

Seefat MR, Cucchi DGJ, Dirven S, Groen K, Zweegman S, Blommestein HM. Seefat MR, et al. Among authors: cucchi dgj. Cancers (Basel). 2021 Nov 9;13(22):5606. doi: 10.3390/cancers13225606. Cancers (Basel). 2021. PMID: 34830761 Free PMC article. Review.

7

Acute perimyocarditis associated with Bartonella henselae infection.

Cucchi DGJ, Govers A, Janse FH, van Dalen BM. Cucchi DGJ, et al. BMJ Case Rep. 2023 Nov 21;16(11):e255928. doi: 10.1136/bcr-2023-255928. BMJ Case Rep. 2023. PMID: 37989328

8

The DRUG Access Protocol: access inequality and European harmonisation.

Polak TB, Cucchi DGJ, van Rosmalen J, Uyl-de Groot CA. Polak TB, et al. Among authors: cucchi dgj. Lancet Oncol. 2022 May;23(5):e202. doi: 10.1016/S1470-2045(22)00098-5. Lancet Oncol. 2022. PMID: 35489346 No abstract available.

9

Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome.

Cucchi DGJ, Groen RWJ, Janssen JJWM, Cloos J. Cucchi DGJ, et al. Drug Resist Updat. 2020 Dec;53:100730. doi: 10.1016/j.drup.2020.100730. Epub 2020 Oct 10. Drug Resist Updat. 2020. PMID: 33096284 Free article. Review.

10

[Expanded Access in The Netherlands: prescribing unregistered medicine].

Polak TB, Cucchi DGJ, van Rosmalen J. Polak TB, et al. Among authors: cucchi dgj. Ned Tijdschr Geneeskd. 2021 Feb 25;165:D5168. Ned Tijdschr Geneeskd. 2021. PMID: 33651496 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year